Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents

Frog skin constitutes a rich source of peptides with a wide range of biological properties. These include host-defense peptides with cytotoxic activities against bacteria, fungi, protozoa, viruses, and mammalian cells. Several hundred such peptides from diverse species have been described. Although attention has been focused mainly on antimicrobial activity, the therapeutic potential of frog skin peptides as anti-infective agents remains to be realized and no compound based upon their structures has yet been adopted in clinical practice. Consequently, alternative applications are being explored. Certain naturally occurring frog skin peptides, and analogs with improved therapeutic properties, show selective cytotoxicity against tumor cells and viruses and so have potential for development into anti-cancer and anti-viral agents. Some peptides display complex cytokine-mediated immunomodulatory properties. Effects on the production of both pro-inflammatory and anti-inflammatory cytokines by peritoneal macrophages and peripheral blood mononuclear cells have been observed so that clinical applications as anti-inflammatory, immunosuppressive, and immunostimulatory agents are possible. Several frog skin peptides, first identified on the basis of antimicrobial activity, have been shown to stimulate insulin release both in vitro and in vivo and so show potential as incretin-based therapies for treatment of patients with Type 2 diabetes mellitus. This review assesses the therapeutic possibilities of peptides from frogs belonging to the Ascaphidae, Alytidae, Pipidae, Dicroglossidae, Leptodactylidae, Hylidae, and Ranidae families that complement their potential role as anti-infectives for use against multidrug-resistant microorganisms.

[1]  J. Conlon,et al.  Insulin releasing properties of the temporin family of antimicrobial peptides. , 2007, Protein Peptide Letters.

[2]  K. Matsuzaki,et al.  Interaction of antimicrobial peptide magainin 2 with gangliosides as a target for human cell binding. , 2012, Biochemistry.

[3]  M. Lukic,et al.  Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent , 2013, Amino Acids.

[4]  H. Atkins,et al.  A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes , 2010, Peptides.

[5]  J. Conlon,et al.  Frog skin peptides (tigerinin-1R, magainin-AM1, -AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cells. , 2013, Biochemical and biophysical research communications.

[6]  Mohammed A Meetani,et al.  Peptidomic analysis of skin secretions from the bullfrog Lithobates catesbeianus (Ranidae) identifies multiple peptides with potent insulin-releasing activity , 2011, Peptides.

[7]  F. Tangy,et al.  The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. , 2005, Virology.

[8]  Octávio L. Franco,et al.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides , 2013, Front. Microbiol..

[9]  B. Gibson,et al.  Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. , 1987, The Biochemical journal.

[10]  J. Conlon.  The contribution of skin antimicrobial peptides to the system of innate immunity in anurans , 2010, Cell and Tissue Research.

[11]  A. Rinaldi,et al.  An immunomodulatory peptide related to frenatin 2 from skin secretions of the Tyrrhenian painted frog Discoglossus sardus (Alytidae) , 2013, Peptides.

[12]  B. Gallwitz.  This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Glucagon-like Peptide-1 Analogues for Type 2 Diabetes Mellitus Current and Emerging Agents , 2011 .

[13]  D. Hoskin,et al.  Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment , 2006, Expert opinion on investigational drugs.

[14]  Antitumor and angiostatic peptides from frog skin secretions , 2010, Amino Acids.

[15]  Vanesa C Albiol Matanic,et al.  Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. , 2004, International journal of antimicrobial agents.

[16]  P. Flatt,et al.  Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevinins-1E and -2EC with novel insulin releasing activity. , 2006, The Journal of endocrinology.

[17]  B. Zinman,et al.  Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies. , 2010, The American journal of medicine.

[18]  P. Flatt,et al.  Characterization of naturally occurring peptides in the skin secretion of Rana pipiens frog reveal pipinin-1 as the novel insulin-releasing agent. , 2005, The journal of peptide research : official journal of the American Peptide Society.

[19]  P. Flatt,et al.  Brevinin-1 and multiple insulin-releasing peptides in the skin of the frog Rana palustris. , 2004, The Journal of endocrinology.

[20]  H. Vaudry,et al.  Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae). , 2007, Toxicon : official journal of the International Society on Toxinology.

[21]  P. Flatt,et al.  Novel Insulin-Releasing Peptides in the Skin of Phyllomedusa trinitatis Frog Include 28 Amino Acid Peptide From Dermaseptin BIV Precursor , 2004, Pancreas.

[22]  Benjamin A Lipsky,et al.  In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. , 1999, Diagnostic microbiology and infectious disease.

[23]  Suzana Popovic,et al.  Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris , 2012, Peptides.

[24]  A. Waring,et al.  Evaluation of the Inactivation of Infectious Herpes Simplex Virus by Host-Defense Peptides , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[25]  D. Srinivasan,et al.  Caerulein precursor fragment (CPF) peptides from the skin secretions of Xenopus laevis and Silurana epitropicalis are potent insulin-releasing agents. , 2013, Biochimie.

[26]  J. Conlon,et al.  A peptide of the phylloseptin family from the skin of the frog Hylomantis lemur (Phyllomedusinae) with potent in vitro and in vivo insulin-releasing activity , 2008, Peptides.

[27]  C. Bailey,et al.  Recent advances in antidiabetic drug therapies targeting the enteroinsular axis. , 2009, Current drug metabolism.

[28]  L. Bryan,et al.  Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides. , 2004, Virology.

[29]  M. Lukic,et al.  Esculentin-2CHa: A host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells , 2013, Peptides.

[30]  O. Lequin,et al.  Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini. , 2006, Biochemistry.

[31]  X. Vila-Farrés,et al.  Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group. , 2012, International journal of antimicrobial agents.

[32]  M. Zasloff,et al.  Anticancer efficacy of Magainin2 and analogue peptides. , 1993, Cancer research.

[33]  W. Kamysz,et al.  Antitumor Activity of Antimicrobial Peptides against U937 Histiocytic Cell Line , 2022 .

[34]  Mohammed A Meetani,et al.  Caerulein-and xenopsin-related peptides with insulin-releasing activities from skin secretions of the clawed frogs, Xenopus borealis and Xenopus amieti (Pipidae). , 2011, General and comparative endocrinology.

[35]  J. Carver,et al.  The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2. , 2000, European journal of biochemistry.

[36]  M. Aouni,et al.  In vitro antiviral activity of dermaseptins against herpes simplex virus type 1 * , 2002, Journal of medical virology.

[37]  P. Flatt,et al.  Tigerinin‐1R: a potent, non‐toxic insulin‐releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus , 2011, Diabetes, obesity & metabolism.

[38]  J. Barker,et al.  Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Lukic,et al.  A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae) , 2014, Peptides.

[40]  E. Giamarellos‐Bourboulis,et al.  Emerging drugs for the treatment of sepsis , 2012, Expert opinion on emerging drugs.

[41]  J. Gies,et al.  Drugs and their molecular targets: an updated overview , 2008, Fundamental & clinical pharmacology.

[42]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .

[43]  Pierre Nicolas,et al.  Dermaseptin S9, an α-Helical Antimicrobial Peptide with a Hydrophobic Core and Cationic Termini† , 2006 .

[44]  J. Wade,et al.  Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa , 2011, European Biophysics Journal.

[45]  K. Hahm,et al.  Different mechanisms of action of antimicrobial peptides: insights from fluorescence spectroscopy experiments and molecular dynamics simulations , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[46]  H. Vaudry,et al.  Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA) , 2012, Peptides.

[47]  Xia Li,et al.  APD2: the updated antimicrobial peptide database and its application in peptide design , 2008, Nucleic Acids Res..

[48]  P. F. Almeida,et al.  Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. , 2009, Biochemistry.

[49]  P. Flatt,et al.  Insulin-releasing properties of the frog skin peptide pseudin-2 and its [Lys18]-substituted analogue , 2008, Biological chemistry.

[50]  Alan Ashworth,et al.  Mechanisms of resistance to therapies targeting BRCA-mutant cancers , 2013, Nature Medicine.

[51]  J. Conlon,et al.  Anti-tumor activities of the host-defense peptide hymenochirin-1B , 2013, Regulatory Peptides.

[52]  J. Conlon,et al.  Structural diversity and species distribution of host-defense peptides in frog skin secretions , 2011, Cellular and Molecular Life Sciences.

[53]  Jiyang Jiang,et al.  Antimicrobial Peptides from Amphibian Skin Potently Inhibit Human Immunodeficiency Virus Infection and Transfer of Virus from Dendritic Cells to T Cells , 2005, Journal of Virology.

[54]  M. V. Sousa,et al.  Anti-proliferative and cytotoxic activity of pentadactylin isolated from Leptodactylus labyrinthicus on melanoma cells , 2009, Amino Acids.

[55]  Jérôme Leprince,et al.  A potent, non-toxic insulin-releasing peptide isolated from an extract of the skin of the Asian frog, Hylarana guntheri (Anura:Ranidae) , 2008, Regulatory Peptides.

[56]  K. Nan,et al.  Agents from amphibians with anticancer properties , 2008, Anti-cancer drugs.

[57]  P. Flatt,et al.  Insulinotropic Actions of the Frog Skin Host‐Defense Peptide Alyteserin‐2a: A Structure–Activity Study , 2013, Chemical biology & drug design.

[58]  Friedrich Paulsen,et al.  Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. , 2006, European urology.

[59]  D. Shang,et al.  Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism , 2013, PloS one.

[60]  M. Lukic,et al.  Effects of tigerinin peptides on cytokine production by mouse peritoneal macrophages and spleen cells and by human peripheral blood mononuclear cells. , 2014, Biochimie.

[61]  N. Irwin,et al.  Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease? , 2010, Expert opinion on investigational drugs.

[62]  J. H. Kim,et al.  Gaegurin-6 stimulates insulin secretion through calcium influx in pancreatic β Rin5mf cells , 2010, Regulatory Peptides.

[63]  P. Flatt,et al.  Isolation and characterisation of an unexpected class of insulinotropic peptides in the skin of the frog Agalychnis litodryas , 2004, Regulatory Peptides.

[64]  M. Lukic,et al.  An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties , 2013, Peptides.

[65]  H. Vaudry,et al.  The alyteserins: Two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae) , 2009, Peptides.

[66]  Conformational analysis of the frog skin peptide, plasticin-L1, and its effects on production of proinflammatory cytokines by macrophages. , 2013, Biochemistry.

[67]  E. Ah-Sing,et al.  Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by Electrofusion , 1996, Diabetes.

[68]  D. Annane,et al.  Emerging drugs for the treatment of sepsis , 2006, Expert opinion on emerging drugs.

[69]  N. Mookherjee,et al.  Cationic Host Defence Peptides: Multifaceted Role in Immune Modulation and Inflammation , 2012, Journal of Innate Immunity.

[70]  Guangshun Wang,et al.  Identification of Novel Human Immunodeficiency Virus Type 1-Inhibitory Peptides Based on the Antimicrobial Peptide Database , 2010, Antimicrobial Agents and Chemotherapy.

[71]  A. Gazdar,et al.  Antitumor activity of magainin analogues against human lung cancer cell lines. , 1992, Cancer research.

[72]  F. Tangy,et al.  In vitro antiviral activity of dermaseptin S4 and derivatives from amphibian skin against herpes simplex virus type 2 , 2013, Journal of medical virology.

[73]  H. Raza,et al.  Design of Potent, Non‐Toxic Antimicrobial Agents Based Upon the Naturally Occurring Frog Skin Peptides, Ascaphin‐8 and Peptide XT‐7 , 2008, Chemical biology & drug design.

[74]  D. Srinivasan,et al.  Insulin-releasing and cytotoxic properties of the frog skin peptide, tigerinin-1R: a structure–activity study , 2014, Peptides.

[75]  R. Harris,et al.  Symbiotic bacteria contribute to innate immune defenses of the threatened mountain yellow-legged frog, Rana muscosa , 2007 .

[76]  Jérôme Leprince,et al.  A glycine-leucine-rich peptide structurally related to the plasticins from skin secretions of the frog Leptodactylus laticeps (Leptodactylidae) , 2009, Peptides.

[77]  Robert E. W. Hancock,et al.  Multifunctional cationic host defence peptides and their clinical applications , 2011, Cellular and Molecular Life Sciences.

[78]  J. Conlon,et al.  Brevinin-2-related Peptide and its [D4K] Analogue Stimulate Insulin Release In Vitro and Improve Glucose Tolerance in Mice Fed a High Fat Diet , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.